Nu Skin Enterprises, Inc. develops and distributes beauty and wellness products worldwide. It provides skin care systems, including ageLOC Spa systems, ageLOC Transformation anti-aging skin care systems, and ageLOC LumiSpa skin treatment and cleansing devices; and ageLOC Boost, as well as a range of other cosmetic and personal care products. The company also offers ageLOC Youth nutritional supplements, ageLOC TR90 weight management and body shaping systems, LifePak nutritional supplements, ageLOC Meta nutritional supplements, and Beauty Focus Collagen+ skin care supplements, as well as other weight management products. In addition, it is involved in the research and product development of skin care products and nutritional supplements. Further, the company operates retail stores and service centers in Mainland China. It sells its products under the Nu Skin, Pharmanex, and ageLOC brands. The company promotes and sells its products directly, as well as through distributors and Website. Nu Skin Enterprises, Inc. was founded in 1984 and is headquartered in Provo, Utah.
Nu Skin Enterprises Price Performance
NUS traded up $0.23 during midday trading on Thursday, hitting $47.20. The stock had a trading volume of 289,099 shares, compared to its average volume of 591,219. The company has a debt-to-equity ratio of 0.41, a quick ratio of 1.38 and a current ratio of 2.30. Nu Skin Enterprises has a 1 year low of $39.40 and a 1 year high of $56.76. The business has a fifty day moving average of $44.00 and a 200 day moving average of $46.26. The company has a market cap of $2.37 billion, a P/E ratio of 21.10 and a beta of 1.16.
Nu Skin Enterprises Dividend Announcement
The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 7th. Shareholders of record on Friday, August 26th will be given a $0.385 dividend. The ex-dividend date is Thursday, August 25th. This represents a $1.54 annualized dividend and a yield of 3.26%. Nu Skin Enterprises's payout ratio is currently 69.37%.
Analyst Upgrades and Downgrades
Several research analysts have recently commented on NUS shares. TheStreet lowered Nu Skin Enterprises from a "b" rating to a "c" rating in a report on Thursday, August 4th. Citigroup boosted their price objective on Nu Skin Enterprises from $45.00 to $47.00 and gave the stock a "neutral" rating in a report on Monday, August 8th. Finally, StockNews.com raised Nu Skin Enterprises from a "hold" rating to a "buy" rating in a report on Wednesday, June 22nd. Two investment analysts have rated the stock with a hold rating and two have given a buy rating to the company's stock. According to data from MarketBeat.com, Nu Skin Enterprises has an average rating of "Moderate Buy" and a consensus price target of $61.00.
Insider Buying and Selling at Nu Skin Enterprises
In other Nu Skin Enterprises news, Chairman Steven Lund sold 900 shares of the business's stock in a transaction that occurred on Friday, June 17th. The stock was sold at an average price of $45.01, for a total value of $40,509.00. Following the completion of the sale, the chairman now owns 26,600 shares in the company, valued at $1,197,266. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. In related news, Chairman Steven Lund sold 900 shares of the company's stock in a transaction that occurred on Friday, June 17th. The stock was sold at an average price of $45.01, for a total transaction of $40,509.00. Following the completion of the transaction, the chairman now owns 26,600 shares in the company, valued at $1,197,266. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. Also, CEO Ryan S. Napierski sold 25,000 shares of the company's stock in a transaction that occurred on Wednesday, May 25th. The shares were sold at an average price of $44.91, for a total value of $1,122,750.00. Following the transaction, the chief executive officer now owns 122,683 shares of the company's stock, valued at approximately $5,509,693.53. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 126,018 shares of company stock worth $5,645,802. 2.80% of the stock is currently owned by insiders.